Clinical trial
A Randomized Phase II Study of Erlotinib Compared to Single Agent Chemotherapy-erlotinib Combination in Pretreated Patients With Advanced NSCLC (NVALT10 Study)
NCT00835471 is registered in ClinicalTrials.gov with Dutch Society of Physicians for Pulmonology and Tuberculosis as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Phase II Study of Erlotinib Compared to Single Agent Chemotherapy-erlotinib Combination in Pretreated Patients With Advanced NSCLC (NVALT10 Study)
- Lead sponsor
- Dutch Society of Physicians for Pulmonology and Tuberculosis
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 31, 2009
- Completion date
- June 30, 2019
- Enrollment
- 195 (actual)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.